Clarity Pharmaceuticals Ltd.ASX: CU6

Positive Guidance from FDA on Phase 3 Prostate Cancer Trial

Jul 4, 2023 at 2:41 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment